Notice is hereby given that the Office of Research Integrity (ORI) has made final findings of scientific misconduct in the following case: Farooq A. Siddiqui, Ph.D., Roswell Park Cancer Institute: The Division of Research Investigations (DRI) of the Office of Research Integrity (ORI) completed an investigation into possible scientific misconduct on the part of Dr. Siddiqui while he was an employee of Roswell Park Memorial Institute. ORI finds that Dr. Siddiqui committed scientific misconduct by misrepresenting data in a published article. The research was supported by a grant award from the National Cancer Institute, National Institutes of Health, Public Health Service (PHS). Dr. Siddiqui agreed not to appeal the misconduct finding as part of a Voluntary Settlement Agreement under which, for a period of two years, he will not apply as a principal or coprincipal investigator in any nonprocurement transactions (grants and cooperative agreements) or as a principal or coprincipal in any contract or subcontract with the United States Government. Dr. Siddiqui also is prohibited from serving on any Public Health Service advisory committee, board, and/or peer review committee for a period of two years. Also, for a two-year period the institution where he is employed will supervise his performance of work on any covered transaction including a periodic review of primary data, and certify the accuracy of any such data used in any United States Government Public Health Service grant application, contract proposal, or which is otherwise publicly reported. He has agreed to submit a letter to the journal Biochemica et Biophysica Acta (BBA) to retract the article entitled \`\`Purification and Immunological Characterization of DNA Polymerase-alpha from Human Acute Lymphoblastic Leukemia Cells\'\' (BBA, 745:154-161, 1983).
